Heterogeneous expression of GAGE, NY‐ESO‐1, MAGE‐A and SSX proteins in esophageal cancer: Implications for immunotherapy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.21219PMID 16003736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical and Molecular Analysis of Human Melanomas for Expression of the Human Cancer-Testis Antigens NY-ESO-1 and LAGE-1

  2004cited by this paper
• NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

  2004cited by this paper
• The cancer/testis genes: review, standardization, and commentary.

  2004cited by this paper
• Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.

  2004cited by this paper
• NY-ESO-1 Expression and Immunogenicity in Esophageal Cancer

  2004cited by this paper
• Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.

  2003cited by this paper
• Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.

  2003cited by this paper
• Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

  2002cited by this paper
• 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

  2002cited by this paper
• Treatment Outcomes of Resected Esophageal Cancer

  2002cited by this paper
• Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.

  2001cited by this paper
• Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

  2001cited by this paper
• Expression of MAGE‐B Genes in Esophageal Squamous Cell Carcinoma

  2001cited by this paper
• MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia

  2001cited by this paper
• Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

  2000cited by this paper
• Expression of MAGE‐antigens in normal tissues and cancer

  2000cited by this paper
• NY-ESO-1 may be a potential target for lung cancer immunotherapy.

  1999cited by this paper
• Expression of MAGE genes in esophageal squamous-cell carcinoma.

  1997cited by this paper
• MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.

  1997cited by this paper
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.

  1997cited by this paper
• Expression of MAGE‐1 Gene by Esophageal Carcinomas

  1995cited by this paper
• Human esophageal carcinomas frequently express the tumor‐rejection antigens of MAGE genes

  1995cited by this paper

• A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets

  2025cites this paper
• Overexpression of cancer testis antigens in gastric cancer and their correlations with the patients’ clinicopathological characteristics

  2025influential citation
• Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers

  2023cites this paper
• Advances in immunotherapy for esophageal squamous cell carcinoma

  2020cites this paper
• Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy

  2019cites this paper
• A Systematic Review and Meta-analysis: Vinegar Consumption on Glycemic Control in Adults with Type 2 Diabetes Mellitus.

  2019influential citation
• NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma

  2018cites this paper
• Xue, Wei and Metheringham, Rachael L. and Brentville, Victoria A. and Gunn, Barbara and Symonds, Peter and Yagita, Hideo and Ramage, Judith M. and Durrant, Lindy (2016) SCIB2, an antibody DNA vaccine encoding NY- ESO-1 epitopes, induces potent antitumor immunity

  2018cites this paper
• Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma

  2018cites this paper
• Overexpression of cancer‐testis antigen melanoma‐associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy

  2018cites this paper
• Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE‐A and NY‐ESO‐1 expression in adenoid cystic carcinoma

  2017cites this paper
• The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study

  2017cites this paper
• Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.

  2017cites this paper
• Immunotherapy in gastrointestinal cancers.

  2017cites this paper
• Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel

  2016cites this paper
• SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade

  2016cites this paper
• New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.

  2015cites this paper
• Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer

  2015cites this paper
• Oesophageal Cancer : strategies to improve outcomes, and identify novel immunological biomarkers and targets

  2014influential citation
• SSX2-4 expression in early-stage non-small cell lung cancer.

  2014cites this paper
• Autoantibodies targeting tumor-associated antigens in metastatic cancer

  2013cites this paper
• Heterogeneous expression of CT10, CT45 and GAGE7 antigens and their prognostic significance in human breast carcinoma.

  2013cites this paper
• Cancer–Testis Antigen Expression in Digestive Tract Carcinomas: Frequent Expression in Esophageal Squamous Cell Carcinoma and Its Precursor Lesions

  2013cites this paper
• Targeting epigenetic mediators of gene expression in thoracic malignancies.

  2012cites this paper
• Circulating DNA markers of gastro-intestinal cancers

  2012influential citation
• Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer

  2012cites this paper
• Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: Identification of specific tumor marker and potential targets for immunotherapy

  2011cites this paper
• Therapeutic vaccines for gastrointestinal cancers.

  2011cites this paper
• MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma

  2011cites this paper
• Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103.

  2011cites this paper
• Apoptoseinduktion durch Taurolidin und rhTRAIL in humanen Ösophagus-Plattenepithelkarzinomzellen

  2011cites this paper
• Cancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment

  2010cites this paper
• Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails

  2010cites this paper
• Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.

  2009cites this paper
• Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

  2009cites this paper
• Recent duplication and positive selection of the GAGE gene family

  2008cites this paper
• MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy.

  2008cites this paper
• Review Epigenetic remodelling of DNA in cancer

  2007cites this paper
• Cancer‐germline gene expression in pediatric solid tumors using quantitative real‐time PCR

  2007cites this paper
• DNA hypomethylation and human diseases.

  2007cites this paper
• Epigenetic remodelling of DNA in cancer.

  2007cites this paper
• Synovial sarcoma arising in the gastric wall: case report and literature review

  2007cites this paper
• Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium.

  2006cites this paper
• NY-ESO-1 immunotherapy for multiple myeloma

  2006cites this paper
• Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy

  2006cites this paper
• Directions in the immune targeting of cancer: Lessons learned from the cancer‐testis Ag NY‐ESO‐1

  2006cites this paper
• Expression of MAGE-A cancer/testis antigens in esophageal squamous cell carcinomas.

  2006cites this paper